The benchmark results are in. After testing the 2025 MacBook Pro with Apple's M5 CPU, here's my in-depth, side-by-side ...
UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in moderate-to-severe hidradenitis suppurativa (HS). BIMZELX, the ...
Blockchain technology has made digital currency transactions increasingly accessible. However, as the number of crypto ...